In sharp contrast, Fah−/− mice treated with rAAV8-SaCas9 targeting either Hgd or Gstz1 experienced sudden weight loss and hypoglycemia and died approximately 4 and 5 days post-NTBC removal, respectively (Fig. 2, b-d). Here, GSTZ1 is linked to Hypoglycemia.